AKT1 and non-small cell lung carcinoma: Curcumin exhibits anti-NSCLC properties by modulating caspase-3 activity and miR-192-5p expression, leading to phosphoinositide 3-kinase (PI3K)/Akt signaling pathway inhibition and apoptosis [147].